Skip to main content
BrainCited

PQQ (Pyrroloquinoline Quinone) के लिए Age-Related Cognitive Decline

C

A double-blind RCT of 64 subjects found 21.5 mg/day PQQ improved memory, attention, and cognitive function after 12 weeks. A separate trial in MCI patients showed cerebral oxygenation increased from 48.4% to 52.8%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dpqq\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

निष्कर्ष

A double-blind RCT of 64 subjects found 21.5 mg/day PQQ improved memory, attention, and cognitive function after 12 weeks. A separate trial in MCI patients showed cerebral oxygenation increased from 48.4% to 52.8%.

Key Study Findings

Randomized Controlled Trial 6 weeks Double-blind
The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in …
Dose: None बनाम: Placebo Outcome: Cognitive function प्रभाव: None P = 0.01

जनसंख्या: Alzheimer's disease patients

Key Statistics

4

अध्ययन

200

प्रतिभागी

Positive

C

ग्रेड

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
10-20 mg/day
cognitivesupport:
20 mg/day

अधिकतम सीमा: Not established; well-tolerated up to 60 mg/day

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None 6 weeks Neutral --

सेवन का सर्वोत्तम समय: With meals

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Headache
  • Insomnia
  • Mild fatigue

ज्ञात अंतःक्रियाएँ

  • No significant drug interactions established

सहनीय अधिकतम सेवन: Not established; well-tolerated up to 60 mg/day

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does PQQ (Pyrroloquinoline Quinone) help with Age-Related Cognitive Decline?
Based on 4 studies with 200 participants, there is limited but promising evidence that PQQ (Pyrroloquinoline Quinone) may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much PQQ (Pyrroloquinoline Quinone) should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 10-20 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of PQQ (Pyrroloquinoline Quinone)?
Reported side effects may include Headache, Insomnia, Mild fatigue. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for PQQ (Pyrroloquinoline Quinone) and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Age-Related Cognitive Decline

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।